Parkwood LLC - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 743 filers reported holding GLAXOSMITHKLINE PLC in Q2 2016. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.

Quarter-by-quarter ownership
Parkwood LLC ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q1 2017$2,048,000
-16.7%
48,585
-23.9%
0.29%
-23.6%
Q4 2016$2,459,000
-0.6%
63,850
+11.3%
0.38%
+2.7%
Q3 2016$2,475,000
-5.0%
57,380
-4.5%
0.37%
-15.6%
Q2 2016$2,605,000
-3.6%
60,107
-9.8%
0.44%
-4.6%
Q1 2016$2,703,000
+480.0%
66,650
+477.1%
0.46%
+524.7%
Q4 2015$466,000
+15.3%
11,549
+10.0%
0.07%
+10.6%
Q3 2015$404,00010,5000.07%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q2 2016
NameSharesValueWeighting ↓
SENZAR ASSET MANAGEMENT, LLC 668,200$30,717,0009.01%
Camber Capital Management LP 1,200,000$55,164,0005.18%
Camber Capital Management LP 1,000,000$45,970,0004.32%
Gary Goldberg Planning Services Inc 178,496$8,205,0003.41%
Hamlin Capital Management, LLC 1,217,870$55,985,0003.36%
Winch Advisory Services, LLC 109,101$5,015,0003.22%
NORTHROAD CAPITAL MANAGEMENT LLC 151,701$6,974,0002.69%
Reynders McVeigh Capital Management, LLC 296,118$13,613,0002.59%
SALEM CAPITAL MANAGEMENT INC 120,520$5,540,0002.58%
Keystone Financial Planning, Inc. 74,338$3,417,0002.58%
View complete list of GLAXOSMITHKLINE PLC shareholders